Liquid drug transfer assembly

Information

  • Patent Grant
  • 8752598
  • Patent Number
    8,752,598
  • Date Filed
    Tuesday, April 17, 2012
    12 years ago
  • Date Issued
    Tuesday, June 17, 2014
    10 years ago
Abstract
Liquid drug transfer assemblies for use with a drug vial having a drug vial opening stopped by a drug vial stopper. The liquid drug transfer assemblies include a drug vial stopper puncturing member for puncturing a drug vial stopper. The liquid drug transfer assemblies also include a drug vial adapter having a drug vial adapter skirt, an upright drug vial adapter port and a drug vial adapter sleeve downward depending opposite the upright drug vial adapter port and in flow communication therewith. The drug vial adapter is slidingly disposed on the drug vial stopper puncturing member such that on mounting the liquid drug transfer assembly on the drug vial, the drug vial stopper puncturing member punctures the drug vial stopper to form a throughgoing puncture bore and the drug vial adapter sleeve lines the puncture bore.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Section 371 of International Application No. PCT/IL2012/000164, filed Apr. 17, 2012, which was published in the English language on Oct. 26, 2012, under International Publication No. WO 2012/143921 A1 and the disclosure of which is incorporated herein by reference.


BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention relates to liquid drug transfer assemblies for liquid drug reconstitution and administration purposes.


2. Background of the Invention


Dual ended dual lumen linear transfer spikes are typically employed for gravitational liquid transfer from a liquid vial containing a liquid component to a drug vial containing a drug component for forming liquid drug contents in the drug vial for administration purposes and simultaneous air transfer from the drug vial to the liquid vial for pressure equalization. The transfer spikes have exposed drug vial stopper and liquid vial stopper puncturing members with sharp vial stopper puncturing tips which pose a danger to users in general and home users in particular. Moreover, it is difficult to accurately center and correctly insert a transfer spike on a vial stopper to ensure that the transfer spike correctly punctures same for flow communication with a vial interior. Furthermore, a user has to manually remove the transfer spike and use other means, for example, a needle, to withdraw the liquid drug contents which can be cumbersome action and lead to a needle stick injury and contamination of the liquid drug contents.


BRIEF SUMMARY OF THE INVENTION

The invention relates to liquid drug transfer assemblies for use with a drug vial including a drug vial bottle containing a drug component and having a drug vial opening stopped by a drug vial stopper. The drug component is typically a powdered drug component but can equally be a liquid drug component of different viscosities. The liquid drug transfer assemblies include a drug vial stopper puncturing member and a drug vial adapter having a substantially cylindrical drug vial adapter skirt with a drug vial adapter top surface, a drug vial adapter body portion for telescopically slidingly receiving a drug vial opening therein and a drug vial adapter skirt margin. The drug vial adapter top surface is formed with an upright drug vial adapter port and a downward depending drug vial adapter sleeve opposite the drug vial adapter port and in flow communication therewith. The drug vial adapter skirt can be optionally formed from a multitude of at least two drug vial adapter flex members. The drug vial adapter skirt can optionally include inwardly directed protrusions for snap fitting onto a drug vial opening. The drug vial adapter skirt margin can be optionally outwardly flared with respect to the drug vial adapter body portion for assisting in guidance of the drug vial adapter on a drug vial. The drug vial adapter is slidingly disposed on the drug vial stopper puncturing member such that its drug vial stopper puncturing member protrudes beyond the drug vial adapter sleeve in a set-up position of the liquid drug transfer assembly.


The liquid drug transfer assembly is mounted on a drug vial such that the drug vial stopper puncturing member punctures the drug vial stopper to form a throughgoing puncture bore and the drug vial adapter sleeve lines the puncture bore through the drug vial stopper. The drug vial adapter sleeve stops the drug vial stopper from sealing itself on withdrawal of the drug vial stopper puncturing member therefrom, thereby maintaining continuous flow communication between the drug vial bottle and the drug vial adapter port. The drug vial adapter sleeve also prevents remnants of the drug vial stopper contaminating liquid drug contents in a drug vial. Suitable medical devices can be readily mounted on the drug vial adapter port for flow communication with the drug vial bottle. Suitable medical devices include inter alia a needleless syringe, an administration line, and the like.


The drug vial stopper puncturing member can be configured as one end of a dual ended dual lumen linear transfer spike including an opposite liquid vial stopper puncturing member for puncturing a liquid vial stopper of a liquid vial containing a liquid component. The liquid component is typically a diluent but can equally contain an active drug component. Such a dual ended dual lumen linear transfer spike enables simultaneous gravitational liquid transfer from a liquid vial to a drug vial for forming liquid drug contents in a drug vial for administration purposes and air transfer from the drug vial to the liquid vial for pressure equalization purposes.


The dual ended dual lumen linear transfer spike can be integrally formed with a liquid vial adapter for mounting onto a liquid vial. Alternatively, the dual ended dual lumen linear transfer spike can be integrally formed with a liquid drug transfer device for use with a discrete liquid vial adapter for mounting onto a liquid vial thereby forming a triple component liquid drug transfer assembly including the drug vial adapter. The liquid drug transfer device includes a transverse directed spacing collar midway along the dual ended dual lumen linear transfer spike, at least two longitudinal directed drug vial legs and at least two longitudinal directed liquid vial legs oppositely directed to the at least two longitudinal directed drug vial legs. The drug vial legs and the liquid vial legs are employed for centering purposes of their corresponding drug vial stopper puncturing tip and liquid vial stopper puncturing tip with respect to their respective vial stoppers.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.


In order to understand the invention and to see how it can be carried out in practice, preferred embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings in which similar parts are likewise numbered, and in which:


In the drawings:



FIG. 1 is a pictorial representation of a first preferred embodiment of a liquid drug transfer assembly including a drug vial stopper puncturing member and a drug vial adapter, a blister pack for long term storage of same, a needleless syringe, and a drug vial;



FIG. 2 is an exploded view of FIG. 1's liquid drug transfer assembly;



FIG. 3 is a longitudinal cross section of FIG. 1's liquid drug transfer assembly in its initial ready to use state along line A-A in FIG. 1;



FIG. 4A is a longitudinal cross section of FIG. 1's liquid drug transfer assembly in a set-up position and disposed co-axial with the drug vial ready for snap fitting thereon;



FIG. 4B is a longitudinal cross section of FIG. 1's liquid drug transfer assembly pursuant to an initial downward depression toward the drug vial;



FIG. 4C is a longitudinal cross section of FIG. 1's liquid drug transfer assembly pursuant to complete snap fitting of the drug vial adapter on the drug vial;



FIG. 4D is a longitudinal cross section of FIG. 1's liquid drug transfer assembly pursuant to removal of the drug vial stopper puncturing member;



FIG. 5 is a longitudinal cross section of an alternative embodiment of FIG. 1's liquid drug transfer assembly including a drug vial stopper puncturing member having a liquid drug access port and an in-line filter;



FIG. 6 is a longitudinal cross section of another alternative embodiment of FIG. 1's drug vial adapter including a drug vial adapter sleeve component mounted on its drug vial adapter top surface;



FIG. 7 is a pictorial representation of a second preferred embodiment of a liquid drug transfer assembly including a liquid vial adapter and a drug vial adapter, a blister pack for long term storage of same, a needleless syringe, a drug vial, and a liquid vial;



FIG. 8 is an exploded view of FIG. 7's liquid drug transfer assembly;



FIG. 9 is a longitudinal cross section of FIG. 7's liquid drug transfer assembly in its initial ready to use state along line B-B in FIG. 7;



FIG. 10A shows FIG. 7's liquid drug transfer assembly co-axial with a drug vial ready for snap fitting thereon;



FIG. 10B shows FIG. 7's liquid drug transfer assembly snap fitted on the drug vial;



FIG. 10C shows inversion of the FIG. 10B assemblage ready for snap fitting on the liquid vial;



FIG. 10D shows the FIG. 10B assemblage snap fitted on the liquid vial;



FIG. 10E shows the FIG. 10D assemblage in an inverted position for enabling gravitational liquid transfer from the liquid vial to the drug vial to form liquid drug contents in the drug vial and venting from the drug vial to the liquid vial;



FIG. 10F shows the drug vial adapter mounted on the drug vial containing liquid drug contents after removal of the liquid drug vial with its attached empty liquid vial;



FIG. 10G shows use of the needleless syringe for aspirating liquid drug contents from the drug vial for administration purposes;



FIG. 11 is a pictorial representation of a third preferred embodiment of a liquid drug transfer assembly including a liquid drug transfer device, a drug vial adapter, and a liquid vial adapter in its initial ready to use state, a blister pack for long term storage of same, a needleless syringe, a drug vial, and a liquid vial;



FIG. 12 is a perspective view of FIG. 11's liquid drug transfer assembly;



FIG. 13 is an exploded view of FIG. 11's liquid drug transfer assembly and an enlarged transverse cross section of the dual ended dual lumen linear transfer spike of the liquid drug transfer device;



FIG. 14 is a longitudinal cross section of FIG. 11's liquid drug transfer assembly in its initial ready to use state along line C-C in FIG. 11;



FIG. 15A is a longitudinal cross section of FIG. 11's liquid drug transfer assembly co-axial with the drug vial ready for snap fitting thereon;



FIG. 15B is a longitudinal cross section of FIG. 11's liquid drug transfer assembly pursuant to an initial downward depression of the liquid drug transfer assembly toward the drug vial;



FIG. 15C is a longitudinal cross section of FIG. 11's liquid drug transfer assembly pursuant to further downward depression of the liquid drug transfer assembly towards the drug vial;



FIG. 15D is a longitudinal cross section of FIG. 11's liquid drug transfer assembly pursuant to still further downward depression of the liquid drug transfer assembly towards the drug vial;



FIG. 15E is a longitudinal cross section of FIG. 11's liquid drug transfer assembly pursuant to complete snap fitting of the drug vial adapter on the drug vial;



FIG. 15F is a longitudinal cross section of FIG. 11's liquid drug transfer assembly showing complete snap fitting of both the drug vial and the liquid vial including snap fit engagement of the liquid drug transfer device and the liquid vial adapter;



FIG. 16A shows FIG. 11's liquid drug transfer assembly co-axial with a drug vial ready for snap fitting thereon;



FIG. 16B shows FIG. 11's liquid drug transfer assembly snap fitted on the drug vial;



FIG. 16C shows inversion of the FIG. 16B assemblage ready for snap fitting on the liquid vial;



FIG. 16D shows the FIG. 16B assemblage snap fitted on the liquid vial;



FIG. 16E shows the FIG. 16D assemblage in an inverted position for enabling gravitational liquid transfer from the liquid vial to the drug vial to form liquid drug contents in the drug vial and venting from the drug vial to the liquid vial;



FIG. 16F shows the drug vial adapter mounted on the drug vial containing liquid drug contents after removal of the liquid drug transfer device and the liquid drug adapter with its attached empty liquid vial; and



FIG. 16G shows use of the needleless syringe for aspirating liquid drug contents from the drug vial for administration purposes.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows a liquid drug transfer assembly 100A for use with a needleless syringe 10 and a drug vial 20. The syringe 10 includes a barrel 11 with a plunger 12 and a male Luer lock connector 13. The syringe 10 can be formed with other types of male connectors. The syringe 10 is filled with a liquid component 14. The liquid component 14 can be diluent only. Alternatively, the liquid component 14 can include an active component. The drug vial 20 has a longitudinal drug vial axis 20A and includes a drug vial bottle 21 having a drug vial shoulder 22 and a drug vial opening 23 sealed by a drug vial stopper 24. The drug vial opening 23 has an uppermost outermost drug vial rim 26. The drug vial 20 contains a drug component 27. The liquid drug transfer assembly 100A is preferably packaged in a blister pack 101A having an internal surface 102 and a protective seal 103.



FIGS. 1 to 3 show the liquid drug transfer assembly 100A includes a drug vial stopper puncturing member 110 having a longitudinal drug vial stopper puncturing member axis 111 and a drug vial adapter 120. The blister pack 101A is shaped and dimensioned to snugly fit the liquid drug transfer assembly 100A inside and employed for mounting same on the drug vial 20. The drug vial stopper puncturing member 110 has a drug vial stopper puncturing tip 112 for puncturing the drug vial stopper 24 and a transverse directed head 113.


The drug vial adapter 120 has a longitudinal drug vial adapter axis 121 and includes a drug vial adapter skirt 122 having a transversely directed drug vial adapter top surface 123 formed with an upright drug vial adapter port 124 and a multitude of six downward depending drug vial adapter flex members 126. The drug vial adapter flex members 126 are provided with internal directed protrusions 127 for snap fitting under the drug vial opening 23 and define a drug vial adapter body portion 128 for snugly receiving the drug vial opening 23. The drug vial adapter flex members 126 define a drug vial adapter skirt margin 129 outwardly flared with respect to the drug vial adapter body portion 128 for assisting in guidance of the drug vial adapter 120 on the drug vial 20. The drug vial adapter port 124 is preferably implemented as a female Luer connector for screw thread engagement of the needleless syringe 10 thereon. Alternatively, the drug vial adapter port 124 can be formed with a wide diameter, for example, for enabling gravitational flow of viscous liquid drug contents from a drug vial 20.


The drug vial adapter 120 also includes a downward depending drug vial adapter sleeve 131 opposite the drug vial adapter port 124 and in flow communication therewith. The drug vial adapter 120 including the drug vial adapter port 124 and the drug vial adapter sleeve 131 can be formed as a single injection plastic molded unit from the same suitable plastic material, for example, polycarbonate, and the like. The drug vial adapter sleeve 131 stops short of the drug vial stopper puncturing tip 112 in an initial set-up position of the liquid drug transfer assembly 100A such that the drug vial stopper puncturing tip 112 protrudes therebeyond. Thus, the drug vial stopper puncturing tip 112 contacts a drug vial stopper 24 before the drug vial adapter sleeve 131 on mounting the liquid drug transfer assembly 100A on the drug vial 20.



FIGS. 4A to 4D show the use of the liquid drug transfer assembly 100A for liquid drug reconstitution and administration as follows:



FIG. 4A shows the liquid drug transfer assembly 100A in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100A towards the latter 20.



FIG. 4B shows initial downward depression of the liquid drug transfer assembly 100A towards the drug vial 20 simultaneously causing the drug vial adapter skirt margin 129 to co-axially align the drug vial adapter 120 with the drug vial 20 and the drug vial stopper puncturing tip 112 to begin to puncture the drug vial stopper 24.



FIG. 4C shows complete snap fitting of the liquid drug transfer assembly 100A on the drug vial 20 including the complete penetration of the drug vial stopper penetrating member 110 through the drug vial stopper 24 to form a throughgoing puncture bore P.



FIG. 4D shows removal of the drug vial stopper penetrating member 110 from the drug vial 20 leaving the drug vial adapter 120 in place. The drug vial adapter sleeve 131 lines the puncture bore P to prevent the drug vial stopper 24 sealing itself. The drug vial adapter sleeve 131 also prevents any drug vial stopper remnants falling into the drug vial bottle to contaminate the vial contents. The needleless syringe 10 can be readily mounted on the female Luer connector 124 for injecting its contents into the drug vial bottle 21 for reconstitution or dilution purposes.



FIG. 5 shows the liquid drug transfer assembly 100A including a drug vial stopper puncturing member 110 having a liquid drug access port 114 with a longitudinal lumen 116 for enabling flow communication access to the drug vial bottle 21 on puncturing of the drug vial stopper 24. The liquid drug access port 114 can be optionally formed as a female Luer connector. The liquid drug access port 114 and/or longitudinal lumen 116 can be optionally formed with an in-line filter 117.



FIG. 6 shows an alternative embodiment of the drug vial adapter 120 including a drug vial adapter sleeve component 133 mounted on its drug vial adapter top surface 123. The drug vial adapter sleeve component 133 can be formed from a material different from the rest of the drug vial adapter 120. Suitable materials include inter alia elastomer materials, metal, neoprene fabrics, rubber, silicone, glass, and the like.



FIG. 7 shows a liquid drug transfer assembly 100B for use with an empty syringe 10, a drug vial 20 and a liquid vial 30. The liquid vial 30 has a longitudinal axis 30A and includes a liquid vial bottle 31 having a liquid vial shoulder 32 and a liquid drug vial opening 33 stopped by a liquid vial stopper 34. The liquid vial opening 33 has an uppermost outermost liquid vial rim 36. The liquid vial 30 contains a liquid component 37 for adding to the drug component 27. The liquid drug transfer assembly 100B is preferably packaged in a blister pack 101B shaped and dimensioned to snugly fit the liquid drug transfer assembly 100B inside and employed for operation of same.



FIGS. 7 to 9 show the liquid drug transfer assembly 100B includes a drug vial adapter 120 and a liquid vial adapter 140. The liquid vial adapter 140 has a longitudinal liquid vial adapter axis 141 and includes a liquid vial adapter skirt 142 having a transversely directed liquid vial adapter top surface 143 formed with a multitude of six downward depending liquid vial adapter flex members 144. The liquid vial adapter flex members 144 are provided with internal directed protrusions 146 for snap fitting under the liquid vial opening 33 and define a liquid vial adapter body portion 147 for snugly receiving the liquid vial opening 33. The liquid vial adapter flex members 144 define a liquid vial adapter skirt margin 148 outwardly flared with respect to the liquid vial adapter body portion 147 for assisting in guidance of the liquid vial adapter 140 on the liquid vial 30.


The liquid vial adapter 140 also includes a dual ended dual lumen linear transfer spike 151 having a drug vial stopper puncturing member 152 for puncturing the drug vial stopper 24 and an opposite liquid vial stopper puncturing member 153 for puncturing the liquid vial stopper 34. The drug vial stopper puncturing member 152 extends from the liquid vial adapter top surface 143 away from the liquid vial adapter skirt 142. The drug vial stopper puncturing member 152 terminates at a drug vial stopper puncturing tip 154 which extends beyond the drug vial adapter sleeve 131 on mounting the liquid drug vial adapter 140 on the drug vial adapter 120. The liquid vial stopper puncturing member 153 extends from the liquid vial adapter top surface 143 into the liquid vial adapter skirt 142. The liquid vial stopper puncturing member 153 terminates at a liquid vial stopper puncturing tip 156. The dual ended dual lumen linear transfer spike 151 includes a liquid transfer lumen 157 for liquid transfer from the liquid vial 30 to the drug vial 20 and an air transfer lumen 158 for air transfer from the drug vial 20 to the liquid vial 30 for pressure equalization purposes.



FIGS. 10A to 10G show the use of the liquid drug transfer assembly 100B for liquid drug reconstitution and administration as follows:



FIG. 10A shows the liquid drug transfer assembly 100B in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100 towards the latter 20.



FIG. 10B shows complete snap fitting of the liquid drug transfer assembly 100B including the complete penetration of the drug vial stopper penetrating member 152 through the drug vial stopper 24 to form a throughgoing puncture bore P.



FIG. 10C shows inversion of the FIG. 10B assemblage ready for snap fitting the liquid vial adapter 140 on the liquid vial 30.



FIG. 4D shows complete snap fitting of the liquid drug transfer assembly 100B including the drug vial 20 on the liquid vial 30.



FIG. 10E shows inversion of the FIG. 10D assemblage for enabling gravitational liquid transfer from the liquid vial 30 to the drug vial 20 to form liquid drug contents LD in the drug vial 20 and venting from the drug vial 20 to the liquid vial 30. A user may gently agitate the inverted FIG. 10D assemblage to facilitate reconstitution or dilution depending on the drug component and the liquid component.



FIG. 10F shows removal of the liquid vial adapter 140 together with its attached empty liquid vial 30 to leave the drug vial 20 with the liquid drug contents LD. The drug vial adapter sleeve 131 lines the puncture bore P to prevent the drug vial stopper sealing itself. The drug vial adapter sleeve 131 also prevents any drug vial stopper remnants falling into the drug vial bottle to contaminate the contents.



FIG. 10G shows use of the needleless syringe 10 for aspirating liquid drug contents LD from the drug vial 20 for administration purposes.



FIGS. 11 to 14 show a liquid drug transfer assembly 100C for use with an empty syringe 10, a drug vial 20 and a liquid vial 30. The liquid drug transfer assembly 100C has a triple component construction including a drug vial adapter 160, a liquid vial adapter 170 and a liquid drug transfer device 180 having a longitudinal liquid drug transfer device axis 181. The liquid drug transfer assembly 100C is preferably packaged in a blister pack 101C shaped and dimensioned to snugly fit the liquid drug transfer assembly 100C inside and employed for operation of same.


The drug vial adapter 160 has the same construction as the drug vial adapter 120 and therefore similar parts are likewise numbered. The drug vial adapter 160 differs from the drug vial adapter 120 insofar as the former 160 includes an opposite pair of drug vial adapter flex members 161 formed with throughgoing drug vial leg tip apertures 162 in the region of the drug vial adapter body portion 128. Also, the drug vial adapter flex members 161 have smooth external surfaces 163 in the region of the drug vial adapter skirt margin 129 as opposed to the ridged surfaces of the drug vial adapter flex members 126.


The liquid vial adapter 170 has the same construction as the liquid vial adapter 140 and therefore similar parts are likewise numbered. The liquid vial adapter 170 differs from the liquid vial adapter 140 insofar as the former 170 includes an opposite pair of liquid vial adapter flex members 171 formed with throughgoing liquid vial leg tip apertures 172 in the region of the liquid vial adapter body portion 147. Also, the liquid vial adapter flex members 171 have smooth external surfaces 173 in the region of the liquid vial adapter skirt margin 148 as opposed to the ridged surfaces of the liquid drug vial adapter flex members 144.


And additionally, the liquid vial adapter 170 is formed without the dual ended dual lumen linear transfer spike 151 and instead has an upright tubular member 174 extending from the liquid vial adapter top surface 143 away from the liquid vial adapter skirt 142. The tubular member 174 includes a transversely directed flange 176.


The liquid drug transfer device 180 has a similar construction to the dual ended dual lumen linear transfer spike 151 and therefore similar parts are likewise numbered. The liquid drug transfer device 180 includes a drug vial stopper puncturing member 152 terminating at a drug vial stopper puncturing tip 154 and an opposite liquid vial stopper puncturing member 153 terminating at a liquid vial stopper puncturing tip 156. The liquid drug transfer device 180 includes a liquid transfer lumen 157 and an air transfer lumen 158. The liquid transfer lumen 157 has a larger lumen cross section area than the air transfer lumen 158. The liquid transfer lumen 157 has a generally crescent transverse cross section which partially wraps around the air transfer lumen 158 thereby reducing the overall transfer spike cross sectional area for facilitating puncturing of the drug and liquid vial stoppers 24 and 34.


The liquid drug transfer device 180 is additionally formed with a transverse directed spacing collar 182 rigidly mounted midway therealong, a pair of longitudinal directed drug vial legs 183 hinged on the spacing collar 182 and extending co-directional with and spaced apart from the drug vial stopper puncturing member 152 and a pair of longitudinal directed liquid vial legs 184 hinged on the spacing collar 182 and extending co-directional with and spaced apart from the liquid vial stopper puncturing member 153. The drug vial legs 183 terminate at drug vial leg tips 186 co-extensive with and inwardly protruding toward the drug vial stopper puncturing tip 154. The drug vial leg tips 186 are intended to be initially inserted into the throughgoing apertures 162. The liquid vial legs 184 terminate at liquid vial leg tips 187 co-extensive with and inwardly protruding toward the liquid vial stopper puncturing tip 156. The liquid vial leg tips 187 are intended to be initially inserted into the throughgoing apertures 172.


The liquid vial legs 184 are preferably each formed with a pair of outwardly directed liquid vial leg protrusions 188 for bearing against the blister pack 101C's internal surface 102 for assisting in the snap fitting of the liquid drug transfer assembly 100C on the drug vial 20.


The liquid drug transfer assembly 100C includes a snap fit arrangement 190 for mechanically attaching the liquid vial adapter 140 to the spacing collar 182 on snap fitting the liquid vial adapter 140 on the liquid vial 30. The snap fit arrangement 190 is constituted by the tubular member 174 and the spacing collar 182 having a pair of snap members 191 for snap fitting on the transversely directed flange 176.



FIGS. 15A to 15E show the operation of the liquid drug transfer assembly 100C for snap fitting on the drug vial 20.



FIG. 15A shows the liquid drug transfer assembly 100C co-axial with the drug vial 20 ready for snap fitting thereon.



FIG. 15B shows an initial downward depression of the liquid drug transfer assembly 100C toward the drug vial 20. The drug vial leg tips 186 urge the drug vial adapter skirt margin 129 to co-axially align the drug vial adapter 120 with the drug vial 20 and the drug vial stopper puncturing tip 156 to begin to puncture the drug vial stopper 24.



FIG. 15C shows further downward depression of the liquid drug transfer assembly 100C towards the drug vial 20 leading to complete snap fitting of the drug vial adapter 120 on the drug vial 20 and complete puncturing of the drug vial stopper 24 to form a throughgoing puncture bore P. The drug vial adapter sleeve 131 lines the follows the puncture bore P. The drug vial rim 26 begins to urge the drug vial leg tips 186 outwardly from their respective drug vial leg tip apertures 162.



FIG. 15D shows still further downward depression of the liquid drug transfer assembly 100C towards the drug vial 20 to cause the drug vial leg tips 186 to leave their respective drug vial leg tip apertures 162 such that the liquid drug transfer device 180 is free to effect a sliding downward movement relative to the drug vial adapter 120. The drug vial leg tips 186 begin to slide down the smooth external surfaces 163 of their respective drug flex members 161.



FIG. 15E shows yet still further downward depression of the liquid drug transfer assembly 100C towards the drug vial 20 leading to the drug vial leg tips 186 resting on the drug vial adapter skirt margin 129.


The liquid drug transfer assembly 100C snap fits onto the liquid vial 30 in a similar manner as it snap fits onto the drug vial 20. The liquid drug transfer device 180 additionally snap fits on the liquid vial adapter 140 for enabling convenient removal of the two components and the empty liquid vial 30 after forming the liquid drug contents in the drug vial 20.



FIG. 15F shows the operation of the snap fit arrangement 190, namely, the snap fit members 191 snapping onto the tubular member 174's flange 176.



FIGS. 16A to 16G show the use of the liquid drug transfer assembly 100C for liquid drug reconstitution and administration as follows:



FIG. 16A shows the liquid drug transfer assembly 100C in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100 towards the latter 20.



FIG. 16B shows the downward depression of the liquid drug transfer assembly 100C towards the drug vial 20 causes the liquid drug transfer device 180 to urge the drug vial adapter 120 downwards to snap fit on the drug vial 20 and the drug vial puncturing member 152 to puncture the drug vial stopper 24 and the drug vial adapter sleeve 131 to line the puncture bore P. Also, the downward movement of the liquid drug transfer device 180 causes the drug vial leg tips 186 to be urged outward from the drug vial adapter 120 and rest on the drug vial adapter skirt margin 129.



FIG. 16C shows inversion of the FIG. 6B assemblage for snap fitting on the liquid vial 30.



FIG. 16D shows the downward depression of the liquid drug transfer assembly 100C towards the drug vial 30 causes the liquid drug transfer device 180 to urge the liquid vial adapter 140 downwards to snap fit on the liquid vial 30 and the liquid vial puncturing member 153 to puncture the liquid vial stopper 24. Also, the downward movement of the liquid drug transfer device 180 causes the liquid vial leg tips 187 to be urged outward from the liquid vial adapter 140 and rest on the liquid vial adapter skirt margin 148. The downward movement also causes the actuation of the snap fit arrangement 190 between the liquid drug transfer device 180 and the liquid drug adapter 140.



FIG. 16E shows inversion of the FIG. 16D assemblage for enabling gravitational liquid transfer from the liquid vial 30 to the drug vial 20 to form liquid drug contents LD in the drug vial 20 and venting from the drug vial 20 to the liquid vial 30. A user may gently agitate the inverted FIG. 16D assemblage to facilitate reconstitution or dilution of the liquid drug contents LD.



FIG. 16F shows the drug vial adapter 120 mounted on the drug vial 20 containing liquid drug contents LD after removal of the liquid drug transfer device 180 together with the liquid drug adapter 140 and its attached empty liquid vial 30.



FIG. 16G shows use of the needleless syringe 10 for aspirating liquid drug contents LD from the drug vial 20 for administration purposes.


While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications, and other applications of the invention can be made within the scope of the appended claims.


It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.

Claims
  • 1. A liquid drug transfer assembly for use with a drug vial including a drug vial bottle containing a drug component and having a drug vial opening stopped by a drug vial stopper, the liquid drug transfer assembly comprising: (a) a drug vial stopper puncturing member with a drug vial stopper puncturing tip for puncturing the drug vial stopper; and(b) a drug vial adapter having a longitudinal drug vial adapter axis and including a drug vial adapter skirt having a transversely directed drug vial adapter top surface formed with an upright drug vial adapter port, a drug vial adapter body portion for snugly receiving the drug vial opening and a drug vial adapter skirt margin remote from said drug vial adapter top surface, and a drug vial adapter sleeve downward depending from said drug vial adapter top surface opposite said upright drug vial adapter port and in flow communication therewith,said drug vial adapter being slidingly disposed on said drug vial stopper puncturing member such that said drug vial stopper puncturing tip protrudes beyond said drug vial adapter sleeve,the arrangement being such that on mounting the liquid drug transfer assembly on the drug vial, said drug vial stopper puncturing member punctures the drug vial stopper to form a throughgoing puncture bore and said drug vial adapter sleeve lines said puncture bore whereby, on withdrawal of said drug vial stopper puncturing member from said puncture bore, said drug vial adapter sleeve prevents the drug vial stopper from sealing itself thereby enabling flow communication between said drug vial adapter port and the drug vial bottle.
  • 2. The assembly according to claim 1, wherein said drug vial adapter skirt, said drug vial adapter port and said drug vial adapter sleeve are formed as a single injection plastic molded unit from the same plastic material.
  • 3. The assembly according to claim 1, wherein said drug vial adapter sleeve is mounted on said drug vial adapter skirt and is formed from a different material therefrom.
  • 4. The assembly according to claim 1, wherein said drug vial stopper puncturing member includes a liquid drug access port and a longitudinal lumen for enabling flow communication access to the drug vial bottle on said puncturing of the drug vial stopper.
  • 5. The assembly according to claim 4, wherein drug vial stopper puncturing member includes an in-line filter.
  • 6. The assembly according to claim 1, for additional use with a liquid vial including a liquid vial bottle containing a liquid component and having a liquid vial opening stopped by a liquid vial stopper, the liquid component intended for adding to the drug component to form liquid drug contents, wherein said drug vial stopper puncturing member is formed as a dual ended dual lumen linear transfer spike integrally formed with a liquid vial adapter including a liquid vial adapter skirt having a transversely directed liquid vial adapter top surface and a liquid vial adapter body portion for snugly receiving the liquid vial opening therein,said dual ended dual lumen linear transfer spike including a liquid vial stopper puncturing member opposite said drug vial stopper puncturing member, said liquid vial stopper puncturing member having a liquid vial stopper puncturing tip for puncturing the liquid vial stopper on mounting the liquid vial adapter on the liquid vial thereby enabling simultaneous gravitational flow of liquid component from the liquid vial to the drug vial and air flow from the drug vial to the liquid vial on forming an upright assemblage of an uppermost liquid vial and a lowermost drug vial for forming liquid drug contents in the drug vial for administration purposes on removal of the liquid vial adapter from the drug vial adapter.
  • 7. The assembly according to claim 1, for additional use with a liquid vial including a liquid vial bottle containing a liquid component and having a liquid vial opening stopped by a liquid vial stopper, the liquid component intended for adding to the drug component to form liquid drug contents, said wherein said drug vial stopper puncturing member is formed as one end of a dual ended dual lumen linear transfer spike having a longitudinal axis and includingi) an opposite directed liquid vial stopper puncturing member with a liquid vial stopper puncturing tip for puncturing the liquid vial stopper,ii) a transverse directed spacing collar rigidly mounted on said linear transfer spike,iii) at least two longitudinal directed drug vial legs mounted on said spacing collar and extending co-directional with and spaced apart from said drug vial stopper puncturing member,said at least two drug vial legs terminating at drug vial leg tips co-extensive with and inwardly protruding toward said drug vial stopper puncturing tip,iv) at least two longitudinal directed liquid vial legs mounted on said spacing collar and extending co-directional with and spaced apart from said liquid vial stopper puncturing member,said at least two liquid vial legs terminating at liquid vial leg tips co-extensive with and inwardly protruding toward said liquid vial stopper puncturing tip,said drug vial adapter being slidingly mounted on said drug vial stopper puncturing member with said drug vial adapter top surface towards said spacing collar and said drug vial adapter skirt margin remote therefrom,said drug vial adapter skirt having drug vial leg tip apertures for initially receiving said drug vial leg tips for initially spacing said drug vial adapter from said spacing collar such that said drug vial adapter skirt margin is further from said spacing collar than said drug vial puncturing tip whereby, on sliding said drug vial adapter towards said spacing collar, said drug vial adapter skirt mounts on the drug vial opening for enclosing the drug vial opening in said drug vial adapter body portion, said drug vial stopper puncturing member punctures the drug vial stopper for flow communication with the drug vial bottle and said drug vial leg tips slide along said drug vial adapter skirt towards said drug vial adapter skirt margin; and(c) a liquid vial adapter including a liquid vial skirt adapter having a transversely directed liquid vial adapter top surface formed with a liquid vial adapter body portion for snugly receiving the liquid vial opening and a liquid vial adapter skirt margin,said liquid vial adapter being slidingly disposed on said liquid vial stopper puncturing member with said liquid vial adapter top surface towards said spacing collar and said liquid vial adapter skirt margin remote therefrom,said liquid vial adapter skirt having liquid vial leg tip apertures for initially receiving said liquid vial leg tips for initially spacing said liquid vial adapter from said spacing collar such that said liquid vial adapter skirt margin is further from said spacing collar than said liquid vial stopper puncturing tip whereby, on sliding said liquid vial adapter towards said spacing collar, said liquid vial adapter skirt mounts on the liquid vial opening for enclosing the liquid vial opening in said liquid vial adapter body portion, said liquid vial stopper puncturing member punctures the liquid vial stopper for flow communication with the liquid vial bottle and said liquid vial leg tips slide along said liquid vial adapter skirt towards said liquid vial adapter skirt margin.
  • 8. The assembly according to claim 7, wherein said liquid drug transfer device and said liquid vial adapter have a snap fit arrangement for mechanically attaching said liquid drug transfer device to said liquid vial adapter on mounting said liquid vial adapter on the liquid vial.
  • 9. The assembly according to claim 8, wherein said snap fit arrangement is constituted by said liquid vial adapter port having a longitudinal directed tubular member directed towards said spacing collar and said spacing collar having at least one snap member for snap fitting on said tubular member.
  • 10. The assembly according to claim 7, wherein said drug vial adapter skirt margin is outwardly flared with respect to said drug vial adapter body portion and includes smooth external surfaces for facilitating said sliding of said drug vial leg tips towards said drug vial adapter skirt margin.
  • 11. The assembly according to claim 7, wherein said liquid vial adapter skirt margin is outwardly flared with respect to said liquid vial adapter body portion and includes smooth external surfaces for facilitating said sliding of said liquid vial leg tips towards said liquid vial adapter skirt margin.
  • 12. The assembly according to claim 7, wherein the liquid drug transfer assembly is packaged in a blister pack and each liquid vial leg has at least one outwardly directed liquid leg vial protrusion for bearing against an internal surface of said blister pack.
Priority Claims (1)
Number Date Country Kind
212420 Apr 2011 IL national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/IL2012/000164 4/17/2012 WO 00 9/17/2013
Publishing Document Publishing Date Country Kind
WO2012/143921 10/26/2012 WO A
US Referenced Citations (584)
Number Name Date Kind
62333 Holl Feb 1867 A
1021681 Jennings, John F. Mar 1912 A
1704817 Ayers Mar 1929 A
1930944 Schmitz, Jr. Oct 1933 A
2326490 Perelson Aug 1943 A
2931668 Baley Apr 1960 A
2968497 Treleman Jan 1961 A
3059643 Barton Oct 1962 A
D198499 Harautuneian Jun 1964 S
3484849 Huebner et al. Dec 1969 A
3618637 Santomieri Nov 1971 A
3757981 Harris, Sr. et al. Sep 1973 A
3788524 Davis et al. Jan 1974 A
3822700 Pennington Jul 1974 A
3826261 Killinger Jul 1974 A
3872992 Larson Mar 1975 A
3885607 Peltier May 1975 A
3938520 Scislowicz et al. Feb 1976 A
3957052 Topham May 1976 A
3977555 Larson Aug 1976 A
3993063 Larrabee Nov 1976 A
4020839 Klapp May 1977 A
4051852 Villari Oct 1977 A
4109670 Slagel Aug 1978 A
4121585 Becker, Jr. Oct 1978 A
4161178 Genese Jul 1979 A
4187848 Taylor Feb 1980 A
4203067 Fitzky et al. May 1980 A
4203443 Genese May 1980 A
4210173 Choksi et al. Jul 1980 A
D257286 Folkman Oct 1980 S
4253501 Ogle Mar 1981 A
4296786 Brignola Oct 1981 A
4303067 Connolly et al. Dec 1981 A
4312349 Cohen Jan 1982 A
4314586 Folkman Feb 1982 A
4328802 Curley et al. May 1982 A
4335717 Bujan et al. Jun 1982 A
D267199 Koenig Dec 1982 S
4376634 Prior et al. Mar 1983 A
D268871 Benham et al. May 1983 S
4392850 Elias et al. Jul 1983 A
4410321 Pearson et al. Oct 1983 A
4411662 Pearson Oct 1983 A
D271421 Fetterman Nov 1983 S
4434823 Hudspith Mar 1984 A
4465471 Harris et al. Aug 1984 A
4475915 Sloane Oct 1984 A
4493348 Lemmons Jan 1985 A
4505709 Froning et al. Mar 1985 A
4507113 Dunlap Mar 1985 A
D280018 Scott Aug 1985 S
4532969 Kwaan Aug 1985 A
4564054 Gustavsson Jan 1986 A
4573993 Hoag et al. Mar 1986 A
4576211 Valentini et al. Mar 1986 A
4581014 Millerd et al. Apr 1986 A
4588396 Stroebel et al. May 1986 A
4588403 Weiss et al. May 1986 A
D284603 Loignon Jul 1986 S
4604093 Brown et al. Aug 1986 A
4607671 Aalto et al. Aug 1986 A
4614437 Buehler Sep 1986 A
4638975 Iuchi et al. Jan 1987 A
4639019 Mittleman Jan 1987 A
4667927 Oscarsson May 1987 A
4676530 Nordgren et al. Jun 1987 A
4683975 Booth et al. Aug 1987 A
4697622 Swift et al. Oct 1987 A
4721133 Sundblom Jan 1988 A
4729401 Raines Mar 1988 A
4735608 Sardam Apr 1988 A
4743229 Chu May 1988 A
4743243 Vaillancourt May 1988 A
4752292 Lopez et al. Jun 1988 A
4758235 Tu Jul 1988 A
4759756 Forman et al. Jul 1988 A
4778447 Velde et al. Oct 1988 A
4787898 Raines Nov 1988 A
4797898 Martinez Jan 1989 A
4804366 Zdeb et al. Feb 1989 A
4832690 Kuu May 1989 A
4834152 Howson et al. May 1989 A
4857062 Russell Aug 1989 A
4865592 Rycroft Sep 1989 A
4909290 Coccia Mar 1990 A
4931040 Haber et al. Jun 1990 A
4932944 Jagger et al. Jun 1990 A
4967797 Manska Nov 1990 A
D314050 Sone Jan 1991 S
D314622 Andersson et al. Feb 1991 S
4997430 Van der Heiden et al. Mar 1991 A
5006114 Rogers et al. Apr 1991 A
5035686 Crittenden et al. Jul 1991 A
5041105 D'Alo et al. Aug 1991 A
5045066 Scheuble et al. Sep 1991 A
5049129 Zdeb et al. Sep 1991 A
5053015 Gross Oct 1991 A
5061248 Sacco Oct 1991 A
5088996 Kopfer et al. Feb 1992 A
5096575 Cosack Mar 1992 A
5104387 Pokorney et al. Apr 1992 A
5113904 Aslanian May 1992 A
5122124 Novacek et al. Jun 1992 A
5125908 Cohen Jun 1992 A
5125915 Berry et al. Jun 1992 A
D328788 Sagae et al. Aug 1992 S
5171230 Eland et al. Dec 1992 A
5201705 Berglund et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5203771 Melker et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
5232029 Knox et al. Aug 1993 A
5232109 Tirrell et al. Aug 1993 A
5242432 DeFrank Sep 1993 A
5247972 Tetreault Sep 1993 A
D341420 Conn Nov 1993 S
5269768 Cheung Dec 1993 A
5270219 DeCastro et al. Dec 1993 A
5279576 Loo et al. Jan 1994 A
5288290 Brody Feb 1994 A
5300034 Behnke et al. Apr 1994 A
5301685 Guirguis Apr 1994 A
5304163 Bonnici et al. Apr 1994 A
5308483 Sklar et al. May 1994 A
5312377 Dalton May 1994 A
5328474 Raines Jul 1994 A
D349648 Tirrell et al. Aug 1994 S
5334163 Sinnett Aug 1994 A
5334179 Poli et al. Aug 1994 A
5342346 Honda et al. Aug 1994 A
5344417 Wadsworth, Jr. Sep 1994 A
5350372 Ikeda et al. Sep 1994 A
5364386 Fukuoka et al. Nov 1994 A
5364387 Sweeney Nov 1994 A
5374264 Wadsworth, Jr. Dec 1994 A
5385547 Wong et al. Jan 1995 A
5397303 Sancoff et al. Mar 1995 A
5429614 Fowles et al. Jul 1995 A
5433330 Yatsko et al. Jul 1995 A
5445630 Richmond Aug 1995 A
5445631 Uchida Aug 1995 A
5451374 Molina Sep 1995 A
5454805 Brony Oct 1995 A
5464111 Vacek et al. Nov 1995 A
5464123 Scarrow Nov 1995 A
5466219 Lynn et al. Nov 1995 A
5466220 Brenneman Nov 1995 A
5470327 Helgren et al. Nov 1995 A
5471994 Guirguis Dec 1995 A
5478337 Okamoto et al. Dec 1995 A
5492147 Challender et al. Feb 1996 A
D369406 Niedospial et al. Apr 1996 S
5505714 Dassa et al. Apr 1996 A
5509433 Paradis Apr 1996 A
5520659 Hedges May 1996 A
5526853 McPhee et al. Jun 1996 A
5527306 Haining Jun 1996 A
5531695 Swisher Jul 1996 A
5547471 Thompson et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554128 Hedges Sep 1996 A
5566729 Grabenkort et al. Oct 1996 A
5569191 Meyer Oct 1996 A
5573281 Keller Nov 1996 A
5578015 Robb Nov 1996 A
5583052 Portnoff et al. Dec 1996 A
5584819 Kopfer Dec 1996 A
5591143 Trombley, III et al. Jan 1997 A
5603706 Wyatt et al. Feb 1997 A
5607439 Yoon Mar 1997 A
5611576 Guala Mar 1997 A
5616203 Stevens Apr 1997 A
5636660 Pfleiderer et al. Jun 1997 A
5641010 Maier Jun 1997 A
5645538 Richmond Jul 1997 A
5647845 Haber et al. Jul 1997 A
5651776 Appling et al. Jul 1997 A
5653686 Coulter et al. Aug 1997 A
5674195 Truthan Oct 1997 A
5676346 Leinsing Oct 1997 A
5685845 Grimard Nov 1997 A
5699821 Paradis Dec 1997 A
5702019 Grimard Dec 1997 A
5718346 Weiler Feb 1998 A
D393722 Fangrow, Jr. et al. Apr 1998 S
5738144 Rogers Apr 1998 A
5743312 Pfeifer et al. Apr 1998 A
5746733 Capaccio et al. May 1998 A
5755696 Caizza May 1998 A
5766211 Wood et al. Jun 1998 A
5772630 Ljungquist Jun 1998 A
5772652 Zielinski Jun 1998 A
RE35841 Frank et al. Jul 1998 E
5776116 Lopez et al. Jul 1998 A
5782872 Muller Jul 1998 A
5806831 Paradis Sep 1998 A
5817082 Niedospial, Jr. et al. Oct 1998 A
5820621 Yale et al. Oct 1998 A
5827262 Neftel et al. Oct 1998 A
5832971 Yale et al. Nov 1998 A
5833213 Ryan Nov 1998 A
5834744 Risman Nov 1998 A
5839715 Leinsing Nov 1998 A
5853406 Masuda et al. Dec 1998 A
5871110 Grimard et al. Feb 1999 A
5873872 Thibault et al. Feb 1999 A
5879337 Kuracina et al. Mar 1999 A
5879345 Aneas Mar 1999 A
5887633 Yale et al. Mar 1999 A
5890610 Jansen et al. Apr 1999 A
5891129 Daubert et al. Apr 1999 A
5893397 Peterson et al. Apr 1999 A
5897526 Vaillancourt Apr 1999 A
5899468 Apps et al. May 1999 A
5902280 Powles et al. May 1999 A
5902298 Niedospial, Jr. et al. May 1999 A
5911710 Barry et al. Jun 1999 A
5919182 Avallone Jul 1999 A
5921419 Niedospial, Jr. et al. Jul 1999 A
5924584 Hellstrom et al. Jul 1999 A
5925029 Jansen et al. Jul 1999 A
5935112 Stevens et al. Aug 1999 A
5941848 Nishimoto et al. Aug 1999 A
5944700 Nguyen et al. Aug 1999 A
5954104 Daubert et al. Sep 1999 A
5971181 Niedospial, Jr. et al. Oct 1999 A
5971965 Mayer Oct 1999 A
5989237 Fowles et al. Nov 1999 A
6003566 Thibault et al. Dec 1999 A
6004278 Botich et al. Dec 1999 A
6019750 Fowles et al. Feb 2000 A
6022339 Fowles et al. Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039093 Mrotzek et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
D422357 Niedospial, Jr. et al. Apr 2000 S
6063068 Fowles et al. May 2000 A
D427308 Zinger Jun 2000 S
6070623 Aneas Jun 2000 A
6071270 Fowles et al. Jun 2000 A
6080132 Cole et al. Jun 2000 A
6086762 Guala Jul 2000 A
6089541 Weinheimer et al. Jul 2000 A
6090091 Fowles et al. Jul 2000 A
6090093 Thibault et al. Jul 2000 A
6099511 Devos et al. Aug 2000 A
6113068 Ryan Sep 2000 A
6113583 Fowles et al. Sep 2000 A
6117114 Paradis Sep 2000 A
6139534 Niedospial, Jr. et al. Oct 2000 A
6142446 Leinsing Nov 2000 A
6146362 Turnbull et al. Nov 2000 A
6156025 Niedospial, Jr. et al. Dec 2000 A
6159192 Fowles et al. Dec 2000 A
6168037 Grimard Jan 2001 B1
6171287 Lynn et al. Jan 2001 B1
6171293 Rowley et al. Jan 2001 B1
6173852 Browne Jan 2001 B1
6174304 Weston Jan 2001 B1
6179822 Niedospial, Jr. Jan 2001 B1
6179823 Niedospial, Jr. Jan 2001 B1
6206861 Mayer Mar 2001 B1
6221041 Russo Apr 2001 B1
6221054 Martin et al. Apr 2001 B1
6221065 Davis Apr 2001 B1
6238372 Zinger et al. May 2001 B1
6245044 Daw et al. Jun 2001 B1
D445501 Niedospial, Jr. Jul 2001 S
D445895 Svendsen Jul 2001 S
6253804 Safabash Jul 2001 B1
6258078 Thilly Jul 2001 B1
6280430 Neftel et al. Aug 2001 B1
6290688 Lopez et al. Sep 2001 B1
6296621 Masuda et al. Oct 2001 B1
6299131 Ryan Oct 2001 B1
6343629 Wessman et al. Feb 2002 B1
6348044 Coletti et al. Feb 2002 B1
6358236 DeFoggi et al. Mar 2002 B1
6364866 Furr et al. Apr 2002 B1
6378576 Thibault et al. Apr 2002 B2
6378714 Jansen et al. Apr 2002 B1
6379340 Zinger et al. Apr 2002 B1
6382442 Thibault et al. May 2002 B1
6408897 Laurent et al. Jun 2002 B1
6409708 Wessman Jun 2002 B1
6440107 Trombley, III et al. Aug 2002 B1
6453949 Chau Sep 2002 B1
6453956 Safabash Sep 2002 B2
6474375 Spero et al. Nov 2002 B2
6478788 Aneas Nov 2002 B1
D468015 Horppu Dec 2002 S
6499617 Niedospial, Jr. et al. Dec 2002 B1
6503240 Niedospial, Jr. et al. Jan 2003 B1
6503244 Hayman Jan 2003 B2
6520932 Taylor Feb 2003 B2
6524278 Campbell et al. Feb 2003 B1
6524295 Daubert et al. Feb 2003 B2
D472316 Douglas et al. Mar 2003 S
6530903 Wang et al. Mar 2003 B2
6537263 Aneas Mar 2003 B1
D472630 Douglas et al. Apr 2003 S
6544246 Niedospial, Jr. Apr 2003 B1
6551299 Miyoshi et al. Apr 2003 B2
6558365 Zinger et al. May 2003 B2
6571837 Jansen et al. Jun 2003 B2
6572591 Mayer Jun 2003 B2
6575955 Azzolini Jun 2003 B2
6581593 Rubin et al. Jun 2003 B1
6582415 Fowles et al. Jun 2003 B1
6591876 Safabash Jul 2003 B2
6601721 Jansen et al. Aug 2003 B2
6626309 Jansen et al. Sep 2003 B1
D482121 Harding et al. Nov 2003 S
D482447 Harding et al. Nov 2003 S
6651956 Miller Nov 2003 B2
6652509 Helgren et al. Nov 2003 B1
D483487 Harding et al. Dec 2003 S
D483869 Tran et al. Dec 2003 S
6656433 Sasso Dec 2003 B2
6666852 Niedospial, Jr. Dec 2003 B2
6681810 Weston Jan 2004 B2
6681946 Jansen et al. Jan 2004 B1
6682509 Lopez Jan 2004 B2
6692478 Paradis Feb 2004 B1
6692829 Stubler et al. Feb 2004 B2
6695829 Hellstrom et al. Feb 2004 B2
6699229 Zinger et al. Mar 2004 B2
6706022 Leinsing et al. Mar 2004 B1
6706031 Manera Mar 2004 B2
6715520 Andreasson et al. Apr 2004 B2
6729370 Norton et al. May 2004 B2
6736798 Ohkubo et al. May 2004 B2
6745998 Doyle Jun 2004 B2
6746438 Arnissolle Jun 2004 B1
6752180 Delay Jun 2004 B2
D495416 Dimeo et al. Aug 2004 S
D496457 Prais et al. Sep 2004 S
6802490 Leinsing et al. Oct 2004 B2
6832994 Niedospial, Jr. et al. Dec 2004 B2
6852103 Fowles et al. Feb 2005 B2
6875203 Fowles et al. Apr 2005 B1
6875205 Leinsing Apr 2005 B2
6878131 Novacek et al. Apr 2005 B2
6890328 Fowles et al. May 2005 B2
6901975 Aramata et al. Jun 2005 B2
6945417 Jansen et al. Sep 2005 B2
6948522 Newbrough et al. Sep 2005 B2
6949086 Ferguson et al. Sep 2005 B2
6957745 Thibault et al. Oct 2005 B2
RE38996 Crawford et al. Feb 2006 E
6994315 Ryan et al. Feb 2006 B2
6997916 Simas, Jr. et al. Feb 2006 B2
6997917 Niedospial, Jr. et al. Feb 2006 B2
7024968 Raudabough et al. Apr 2006 B2
7070589 Lolachi et al. Jul 2006 B2
7074216 Fowles et al. Jul 2006 B2
7083600 Meloul Aug 2006 B2
7086431 D'Antonio et al. Aug 2006 B2
7100890 Cote, Sr. et al. Sep 2006 B2
7150735 Hickle Dec 2006 B2
7192423 Wong Mar 2007 B2
7195623 Burroughs et al. Mar 2007 B2
7241285 Dikeman Jul 2007 B1
7294122 Kubo et al. Nov 2007 B2
7306199 Leinsing et al. Dec 2007 B2
D561348 Zinger et al. Feb 2008 S
7326188 Russell et al. Feb 2008 B1
7326194 Zinger et al. Feb 2008 B2
7350764 Raybuck Apr 2008 B2
7354422 Riesenberger et al. Apr 2008 B2
7354427 Fangrow Apr 2008 B2
7425209 Fowles et al. Sep 2008 B2
7435246 Zihlmann Oct 2008 B2
7452348 Hasegawa Nov 2008 B2
7470257 Norton et al. Dec 2008 B2
7470265 Brugger et al. Dec 2008 B2
7472932 Weber et al. Jan 2009 B2
7488297 Flaherty Feb 2009 B2
7491197 Jansen et al. Feb 2009 B2
7497848 Leinsing et al. Mar 2009 B2
7523967 Steppe Apr 2009 B2
7530546 Ryan et al. May 2009 B2
D595420 Suzuki et al. Jun 2009 S
D595421 Suzuki et al. Jun 2009 S
7540863 Haindl Jun 2009 B2
7540865 Griffin et al. Jun 2009 B2
7544191 Peluso et al. Jun 2009 B2
D595862 Suzuki et al. Jul 2009 S
D595863 Suzuki et al. Jul 2009 S
7611487 Woehr et al. Nov 2009 B2
7611502 Daly Nov 2009 B2
7615041 Sullivan et al. Nov 2009 B2
7628779 Aneas Dec 2009 B2
7632261 Zinger et al. Dec 2009 B2
D608900 Giraud et al. Jan 2010 S
7654995 Warren et al. Feb 2010 B2
7695445 Yuki Apr 2010 B2
D616090 Kawamura May 2010 S
7713247 Lopez May 2010 B2
7717886 Lopez May 2010 B2
7722090 Burton et al. May 2010 B2
D616984 Gilboa Jun 2010 S
7731678 Tennican et al. Jun 2010 B2
7743799 Mosler et al. Jun 2010 B2
7758082 Weigel et al. Jul 2010 B2
7762524 Cawthon et al. Jul 2010 B2
7766304 Phillips Aug 2010 B2
7771383 Truitt et al. Aug 2010 B2
7799009 Niedospial, Jr. et al. Sep 2010 B2
7803140 Fangrow, Jr. Sep 2010 B2
D627216 Fulginiti Nov 2010 S
D630732 Lev et al. Jan 2011 S
7862537 Zinger et al. Jan 2011 B2
7867215 Akerlund et al. Jan 2011 B2
7879018 Zinger et al. Feb 2011 B2
D634007 Zinger et al. Mar 2011 S
7900659 Whitley et al. Mar 2011 B2
D637713 Nord et al. May 2011 S
D644104 Maeda et al. Aug 2011 S
7993328 Whitley Aug 2011 B2
8016809 Zinger et al. Sep 2011 B2
8025653 Capitaine et al. Sep 2011 B2
8029472 Leinsing et al. Oct 2011 B2
8038123 Ruschke et al. Oct 2011 B2
8066688 Zinger et al. Nov 2011 B2
8070739 Zinger et al. Dec 2011 B2
8096525 Ryan Jan 2012 B2
8105314 Fangrow, Jr. Jan 2012 B2
D655017 Mosler et al. Feb 2012 S
8122923 Kraus et al. Feb 2012 B2
D655071 Davila Mar 2012 S
8157784 Rogers Apr 2012 B2
8167863 Yow May 2012 B2
8172824 Pfeifer et al. May 2012 B2
8177768 Leinsing May 2012 B2
8182452 Mansour et al. May 2012 B2
8197459 Jansen et al. Jun 2012 B2
8211069 Fangrow, Jr. Jul 2012 B2
8225959 Lambrecht Jul 2012 B2
8241268 Whitley Aug 2012 B2
8262628 Fangrow, Jr. Sep 2012 B2
D669980 Lev et al. Oct 2012 S
8287513 Ellstrom et al. Oct 2012 B2
D674088 Lev et al. Jan 2013 S
8454573 Wyatt et al. Jun 2013 B2
8480646 Nord et al. Jul 2013 B2
8506548 Okiyama Aug 2013 B2
8523837 Wiggins et al. Sep 2013 B2
8545476 Ariagno et al. Oct 2013 B2
8551067 Zinger et al. Oct 2013 B2
8556879 Okiyama Oct 2013 B2
20010000347 Hellstrom et al. Apr 2001 A1
20010025671 Safabash Oct 2001 A1
20010029360 Miyoshi et al. Oct 2001 A1
20010051793 Weston Dec 2001 A1
20020017328 Loo Feb 2002 A1
20020066715 Niedospial Jun 2002 A1
20020087118 Reynolds et al. Jul 2002 A1
20020087141 Zinger et al. Jul 2002 A1
20020087144 Zinger et al. Jul 2002 A1
20020121496 Thiebault et al. Sep 2002 A1
20020123736 Fowles et al. Sep 2002 A1
20020127150 Sasso Sep 2002 A1
20020128628 Fathallah Sep 2002 A1
20020173752 Polzin Nov 2002 A1
20020193777 Aneas Dec 2002 A1
20030028156 Juliar Feb 2003 A1
20030036725 Lavi et al. Feb 2003 A1
20030068354 Reif et al. Apr 2003 A1
20030073971 Saker Apr 2003 A1
20030100866 Reynolds May 2003 A1
20030120209 Jensen et al. Jun 2003 A1
20030153895 Leinsing Aug 2003 A1
20030187420 Akerlund et al. Oct 2003 A1
20030191445 Wallen et al. Oct 2003 A1
20030195479 Kuracina et al. Oct 2003 A1
20030199846 Fowles et al. Oct 2003 A1
20030199847 Akerlund et al. Oct 2003 A1
20040024354 Reynolds Feb 2004 A1
20040044327 Hasegawa Mar 2004 A1
20040073189 Wyatt et al. Apr 2004 A1
20040153047 Blank et al. Aug 2004 A1
20040181192 Cuppy Sep 2004 A1
20040204699 Hanly et al. Oct 2004 A1
20040217315 Doyle Nov 2004 A1
20040236305 Jansen et al. Nov 2004 A1
20050015070 Delnevo et al. Jan 2005 A1
20050055008 Paradis et al. Mar 2005 A1
20050124964 Niedospial et al. Jun 2005 A1
20050137566 Fowles et al. Jun 2005 A1
20050148994 Leinsing Jul 2005 A1
20050159724 Enerson Jul 2005 A1
20050182383 Wallen Aug 2005 A1
20050261637 Miller Nov 2005 A1
20060030832 Niedospial et al. Feb 2006 A1
20060079834 Tennican et al. Apr 2006 A1
20060089594 Landau Apr 2006 A1
20060089603 Truitt et al. Apr 2006 A1
20060095015 Hobbs et al. May 2006 A1
20060106360 Wong May 2006 A1
20060135948 Varma Jun 2006 A1
20060253084 Nordgren Nov 2006 A1
20070024995 Hayashi Feb 2007 A1
20070060904 Vedrine et al. Mar 2007 A1
20070079894 Kraus et al. Apr 2007 A1
20070083164 Barrelle et al. Apr 2007 A1
20070088252 Pestotnik et al. Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088313 Zinger et al. Apr 2007 A1
20070106244 Mosler et al. May 2007 A1
20070112324 Hamedi-Sangsari May 2007 A1
20070156112 Walsh Jul 2007 A1
20070167904 Zinger et al. Jul 2007 A1
20070191760 Iguchi et al. Aug 2007 A1
20070191764 Zihlmann Aug 2007 A1
20070191767 Hennessy et al. Aug 2007 A1
20070219483 Kitani et al. Sep 2007 A1
20070244461 Fangrow Oct 2007 A1
20070244462 Fangrow Oct 2007 A1
20070244463 Warren et al. Oct 2007 A1
20070249995 Van Manen Oct 2007 A1
20070255202 Kitani et al. Nov 2007 A1
20070265574 Tennican et al. Nov 2007 A1
20070265581 Funamura et al. Nov 2007 A1
20070270778 Zinger et al. Nov 2007 A9
20070287953 Ziv et al. Dec 2007 A1
20070299404 Katoh et al. Dec 2007 A1
20080009789 Zinger et al. Jan 2008 A1
20080009822 Enerson Jan 2008 A1
20080172024 Yow Jul 2008 A1
20080249479 Zinger et al. Oct 2008 A1
20080249498 Fangrow Oct 2008 A1
20080287905 Hiejima et al. Nov 2008 A1
20080294100 de Costa et al. Nov 2008 A1
20080306439 Nelson et al. Dec 2008 A1
20080312634 Helmerson et al. Dec 2008 A1
20090012492 Zihlmann Jan 2009 A1
20090082750 Denenburg et al. Mar 2009 A1
20090143758 Okiyama Jun 2009 A1
20090177177 Zinger et al. Jul 2009 A1
20090177178 Pedersen Jul 2009 A1
20090187140 Racz Jul 2009 A1
20090216212 Fangrow, Jr. Aug 2009 A1
20090267011 Hatton et al. Oct 2009 A1
20090299325 Vedrine et al. Dec 2009 A1
20090326506 Hasegawa et al. Dec 2009 A1
20100010443 Morgan et al. Jan 2010 A1
20100022985 Sullivan et al. Jan 2010 A1
20100030181 Helle et al. Feb 2010 A1
20100036319 Drake et al. Feb 2010 A1
20100076397 Reed et al. Mar 2010 A1
20100087786 Zinger et al. Apr 2010 A1
20100137827 Warren et al. Jun 2010 A1
20100168712 Tuckwell et al. Jul 2010 A1
20100179506 Shemesh et al. Jul 2010 A1
20100204670 Kraushaar et al. Aug 2010 A1
20100241088 Ranalletta et al. Sep 2010 A1
20100274184 Chun Oct 2010 A1
20100286661 Raday et al. Nov 2010 A1
20100312220 Kalitzki Dec 2010 A1
20110054440 Lewis Mar 2011 A1
20110224640 Kuhn et al. Sep 2011 A1
20110230856 Kyle et al. Sep 2011 A1
20110264069 Bochenko Oct 2011 A1
20110276007 Denenburg Nov 2011 A1
20110319827 Leinsing et al. Dec 2011 A1
20120022469 Alpert Jan 2012 A1
20120053555 Ariagno et al. Mar 2012 A1
20120059346 Sheppard et al. Mar 2012 A1
20120078214 Finke et al. Mar 2012 A1
20120123382 Kubo May 2012 A1
20120184938 Lev et al. Jul 2012 A1
20120215182 Mansour et al. Aug 2012 A1
20120220977 Yow Aug 2012 A1
20120220978 Lev et al. Aug 2012 A1
20120265163 Cheng et al. Oct 2012 A1
20120296307 Holt et al. Nov 2012 A1
20120310203 Khaled et al. Dec 2012 A1
20130053814 Mueller-Beckhaus et al. Feb 2013 A1
20130096493 Kubo et al. Apr 2013 A1
20130199669 Moy et al. Aug 2013 A1
20130289530 Wyatt et al. Oct 2013 A1
Foreign Referenced Citations (108)
Number Date Country
1913926 Sep 1970 DE
4122476 Jan 1993 DE
19504413 Aug 1996 DE
202004012714 Nov 2004 DE
202009011019 Dec 2010 DE
0192661 Sep 1986 EP
0195018 Sep 1986 EP
0258913 Mar 1988 EP
0416454 Mar 1991 EP
0518397 Dec 1992 EP
0521460 Jan 1993 EP
0637443 Feb 1995 EP
0737467 Oct 1996 EP
761562 Mar 1997 EP
765652 Apr 1997 EP
765853 Apr 1997 EP
0806597 Nov 1997 EP
0814866 Jan 1998 EP
829248 Mar 1998 EP
0856331 Aug 1998 EP
882441 Dec 1998 EP
0887885 Dec 1998 EP
897708 Feb 1999 EP
0898951 Mar 1999 EP
960616 Dec 1999 EP
1008337 Jun 2000 EP
1029526 Aug 2000 EP
1034809 Sep 2000 EP
1051988 Nov 2000 EP
1323403 Jul 2003 EP
1329210 Jul 2003 EP
1396250 Mar 2004 EP
1454609 Sep 2004 EP
1454650 Sep 2004 EP
1498097 Jan 2005 EP
1872824 Jan 2008 EP
1919432 May 2008 EP
1930038 Jun 2008 EP
2351548 Aug 2011 EP
2351549 Aug 2011 EP
2029242 Oct 1970 FR
2856660 Dec 2004 FR
2869795 Nov 2005 FR
2931363 Nov 2009 FR
1444210 Jul 1976 GB
171662 Oct 2005 IL
03-062426 Sep 1991 JP
4329954 Nov 1992 JP
06-050656 Jul 1994 JP
H08-000710 Jan 1996 JP
09-104460 Apr 1997 JP
09-104461 Apr 1997 JP
10-118158 May 1998 JP
H10-504736 May 1998 JP
11503627 Mar 1999 JP
11-319031 Nov 1999 JP
2000-508934 Jul 2000 JP
2000-237278 Sep 2000 JP
2001-505083 Apr 2001 JP
2002-035140 Feb 2002 JP
2002-516160 Jun 2002 JP
2002-355318 Dec 2002 JP
2003-033441 Feb 2003 JP
2003-102807 Apr 2003 JP
2004-097253 Apr 2004 JP
2004-522541 Jul 2004 JP
9403373 Feb 1994 WO
9507066 Mar 1995 WO
9600053 Jan 1996 WO
9629113 Sep 1996 WO
9736636 Oct 1997 WO
9832411 Jul 1998 WO
9837854 Sep 1998 WO
9961093 Dec 1999 WO
0128490 Apr 2001 WO
0130425 May 2001 WO
0132524 May 2001 WO
0160311 Aug 2001 WO
0191693 Dec 2001 WO
0209797 Feb 2002 WO
0236191 May 2002 WO
02089900 Nov 2002 WO
03051423 Jun 2003 WO
03079956 Oct 2003 WO
2004041148 May 2004 WO
2005002492 Jan 2005 WO
2005041846 May 2005 WO
2005105014 Nov 2005 WO
2006099441 Sep 2006 WO
2007015233 Feb 2007 WO
2007017868 Feb 2007 WO
2007052252 May 2007 WO
2007105221 Sep 2007 WO
2009026443 Feb 2009 WO
2009029010 Mar 2009 WO
2009038860 Mar 2009 WO
2009038860 Mar 2009 WO
2009040804 Apr 2009 WO
2009087572 Jul 2009 WO
2009093249 Jul 2009 WO
2009112489 Sep 2009 WO
2009146088 Dec 2009 WO
2011058545 May 2011 WO
2011058548 May 2011 WO
2011077434 Jun 2011 WO
2011104711 Sep 2011 WO
2012143921 Oct 2012 WO
2013127813 Sep 2013 WO
Non-Patent Literature Citations (105)
Entry
Office Action issued Nov. 11, 2013 in IL Application No. 218730.
U.S. Appl. No. 29/478,723 by Lev, filed Jan. 8, 2014.
U.S. Appl. No. 29/478,726 by Lev, filed Jan. 8, 2014.
Office Action issued Jan. 2, 2014 in U.S. Appl. No. 13/505,881 by Lev.
Office Action issued Mar. 6, 2012 in U.S. Appl. No. 12/678,928.
Int'l Search Report issued Feb. 3, 2011 in Int'l Application No. PCT/IL2010/000777; Written Opinion.
Int'l Search Report issued Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000854; Written Opinion.
Int'l Search Report issued Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000915; Written Opinion.
U.S. Appl. No. 13/505,790 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/505,881 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/522,410 by Lev, filed Jul. 16, 2012.
U.S. Appl. No. 13/576,461 by Lev, filed Aug. 1, 2012.
Office Action issued Jun. 14, 2012 in U.S. Appl. No. 29/376,980.
Office Action issued Jun. 15, 2012 in U.S. Appl. No. 29/413,170.
Office Action issued Jun. 21, 2012 in U.S. Appl. No. 12/596,167.
Alaris Medical Systems Product Brochure, 4 pages, Issue 1, Oct. 11, 1999.
Smart Site Needle-Free Systems, Alaris Medical Systems Webpage, 4 pages, Feb. 2006.
Photographs of Alaris Medical Systems SmartSite.RTM. device, 5 pages, 2002.
Non-Vented Vial Access Pin with ULTRASITE.RTM. Valve, B. Braun Medical, Inc. website and product description, 3 pages, Feb. 2006.
Int'l Search Report issued Aug. 16, 2012 in Int'l Application No. PCT/IL2012/000164.
U.S. Appl. No. 29/438,134 by Lev, filed Nov. 27, 2012.
U.S. Appl. No. 29/438,141 by Gilboa, filed Nov. 27, 2012.
Int'l Search Report issued Jan. 22, 2013 in Int'l Application No. PCT/IL2012/000354.
Int'l Search Report issued Mar. 18, 2013 in Int'l Application No. PCT/IL2012/050516.
Office Action issued Apr. 2, 2013 in U.S. Appl. No. 13/505,790.
Int'l Search Report and Written Opinion issued Mar. 6, 2012 in Int'l Application No. PCT/IL2011/000834.
U.S. Appl. No. 13/883,289 by Lev, filed May 3, 2013.
Int'l Search Report & Written Opinion issued on Mar. 7, 2012 in Int'l Application No. PCT/IL2011/000829.
U.S. Appl. No. 13/884,981 by Denenburg, filed May 13, 2013.
Office Action issued May 31, 2013 in U.S. Appl. No. 13/505,790.
Int'l Search Report issued Jun. 5, 2013 in Int'l Application No. PCT/IL2012/050407.
Int'l Search Report issued Jun. 19, 2013 in Int'l Application No. PCT/IL201/050167.
Int'l Search Report issued Jul. 1, 2013 in Int'l Application No. PCT/IL2013/050180.
Int'l Search Report issued Jul. 31, 2103 in Int'l Application No. PCT/IL2013/050313.
Int'l Search Report issued Jul. 26, 2013 in Int'l Application No. PCT/IL2013/050316.
English translation of an Office Action issued Jun. 19, 2013 in JP Application No. 2012-531551.
Office Action issued Aug. 20, 2013 in U.S. Appl. No. 13/576,461 by Lev.
International Search Report Issued Jan. 23, 2007 in Int'l Application No. PCT/IL/2006/001228.
IV disposables sets catalogue, Cardinal Health, Alaris® products, SmartSite® access devices and accessories product No. 10013365, SmartSite add-on bag access device with spike adapter and needle-free valve bag access port, pp. 1-5, Fall edition (2007).
Office Action Issued Jun. 8, 2010 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action issued 09/28/10 in U.S. Appl. No. 12/112,490 by Zinger.
Article with picture of West Pharmaceutical Services' Vial2Bag Needleless System, [on-line]; ISIPS Newsletter, Oct. 26, 2007]; retrieved from Internet Feb. 16, 2010]; URL:<http://www.isips.org/reports/ISIPS—Newsletter—October—26—2007. html.> (7 pages. see pp. 5-6).
Office Action issued Jun. 15, 2011 in JP Application No. 2008-538492.
Translation of Office Action issued Jun. 18, 2012 in JP Application No. 2008-538492.
Translation of Office Action issued Apr. 15, 2013 in JP Application No. 2008-538492.
Office Action issued Jul. 13, 2012 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action issued Jan. 23, 2013 in U.S. Appl. No. 12/112,490 by Zinger.
Int'l Preliminary Report on Patentability issued May 6, 2008 in Int'l Application No. PCT/IL2006/001228.
Written Opinion issued Aug. 16, 2012 in Int'l Application No. PCT/IL2012/000164.
English translation of an Office Action issued Sep. 10, 2013 in JP Application No. 2012-554468.
Int'l Search Report issued Jun. 19, 2013 in Int'l Application No. PCT/IL2013/050167.
English translation of an Office Action issued Jul. 26, 2013 in JP Application No. 2012-538464.
Drug Administration Systems product information sheets; http://www.westpharma.com/eu/en/products/Pages/Vial2Bag.aspx; pp. 1-3 (admitted prior art as of at least Apr. 1, 2010).
Office Action issued Feb. 13, 2014 in U.S. Appl. No. 13/884,981 by Denenburg.
U.S. Appl. No. 14/345,094 by Lev, filed Mar. 14, 2014.
Grifols Vial Adapter Product Literature, 2 pages, Jan. 2002.
Novel Transfer, Mixing and Drug Delivery Systems, MOP Medimop Medical Projects Ltd. Catalog, 4 pages, Rev. 4, 2004.
Office Action Issued Oct. 6, 2003 in U.S. Appl. No. 10/062,796.
Office Action Issued Feb. 22, 2005 in U.S. Appl. No. 10/062,796.
Office Action Issued Oct. 5, 2005 in U.S. Appl. No. 10/062,796.
Office Action Issued Feb. 20, 2009 in U.S. Appl. No. 11/694,297.
Int'l Search Report Issued Dec. 6, 2006 in Int'l Application No. PCT/IL2006/000912.
Int'l Preliminary Report on Patentability Issued Dec. 4, 2007 in Int'l Application No. PCT/IL2006/000912.
http://www.westpharma.com/en/products/Pages/Mixject.aspx (admitted prior art).
http://www.westpharma.com/SiteCollectionDocuments/Recon/mixject%20product%20sheet.pdf; Mixject product information sheet pp. 1. (admitted prior art).
Int'l Search Report Issued Jul. 27, 2007 in Int'l Application No. PCT/IL2007/000343.
Int'l Preliminary Report on Patentability Issued Jun. 19, 2008 in Int'l Application No. PCT/IL2007/000343.
Int'l Search Report Issued Mar. 27, 2009 in Int'l Application No. PCT/US2008/070024.
Int'l Search Report Issued Oct. 17, 2005 in Int'l Application No. PCT/IL2005/000376.
Int'l Preliminary Report on Patentability Issued Jun. 19, 2006 in Int'l Application No. PCT/IL2005/000376.
Written Opinion of ISR Issued in Int'l Application No. PCT/IL2005/000376.
Int'l Search Report Issued Aug. 25, 2008 in Int'l Application No. PCT/IL2008/000517.
Written Opinion of the ISR Issued Oct. 17, 2009 in Int'l Application No. PCT/IL08/00517.
Int'l Preliminary Report on Patenability Issued Oct. 20, 2009 in Int'l Application No. PCT/IL2008/000517.
Written Opinion of the Int'l Searching Authority Issued Oct. 27, 2008 in Int'l Application No. PCT/US2008/070024.
Int'l Search Report Issued Mar. 12, 2009 in Int'l Application No. PCT/IL2008/001278.
Office Action Issued Jan. 20, 2010 in JP Application No. 2007-510229.
Office Action Issued Apr. 20, 2010 in U.S. Appl. No. 11/997,569.
Int'l Search Report dated Nov. 20, 2006 in Int'l Application No. PCT/IL2006/000881.
Office Action Issued May 27, 2010 in U.S. Appl. No. 11/559,152.
Decision to Grant mailed Apr. 12, 2010 in EP Application No. 08738307.1.
Office Action issued Jun. 1, 2010 in U.S. Appl. No. 11/568,421.
Office Action issued Nov. 12, 2010 in U.S. Appl. No. 29/334,697.
The MixJect transfer system, as shown in the article, “Advanced Delivery Devices,” Drug Delivery Technology Jul./Aug. 2007 vol. 7 No. 7 [on-line]. [Retrieved from Internet May 14, 2010.] URL: <http://www.drugdeiverytech-online.com/drugdelivery/200707/?pg=28pg28>. (3 pages).
Publication date of Israeli Patent Application 186290 [on-line]. ]Retrieved from Internet May 24, 2010]. URL:<http://www.ilpatsearch.justrice.gov.il/UI/Requestslist.aspx>. (1 page).
Int'l Search Report issued Nov. 25, 2010 in Int'l Application No. PCT/IL2010/000530.
Office Action issued Feb. 7, 2011 in U.S. Appl. No. 12/783,194.
Office Action issued Dec. 20, 2010 in U.S. Appl. No. 12/063,176.
Office Action issued Dec. 13, 2010 in U.S. Appl. No. 12/293,122.
Office Action issued Nov. 29, 2010 in U.S. Appl. No. 11/568,421.
Office Action issued Dec. 23, 2010 in U.S. Appl. No. 29/334,696.
Int'l Search Report issued on Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000854.
http://www.knovel.com/web/portal/browse/display?—EXT—KNOVEL—DISPLAY—bookid=1023&VerticalID=0 [retrieved on Feb. 9, 2011].
Int'l Search Report issued on Mar. 17, 2011 in Int'l Application No. PCT/IL2010/00915.
Office Action Issued May 12, 2011 in U.S. Appl. No. 12/063,176.
Office Action issued Jul. 11, 2011 in U.S. Appl. No. 12/293,122.
Int'l Search Report issued Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000187.
Int'l Search Report issued Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000186.
Office Action issued Aug. 3, 2011 in JP Application No. 2008-525719.
Int'l Search Report issued Oct. 7, 2011 in Int'l Application No. PCT/IL2011/000511.
Int'l Search Report issued Mar. 6, 2012 in Int'l Application No. PCT/IL2011/000834; Written Opinion.
Office Action issued Mar. 1, 2012 in JP Application No. 2007-510229.
Int'l Search Report issued Mar. 7, 2012 in Int'l Application No. PCT/IL2011/000829; Written Opinion.
Office Action issued Mar. 13, 2012 in CA Application No. 2,563,643.
Office Action issued Mar. 1, 2012 in CN Application No. 2008801108283.4.
Related Publications (1)
Number Date Country
20140020793 A1 Jan 2014 US